Bioelectronics Corp (BIEL)

[GetSeriousOK]

Any potential buyer/merger candidate would read BIEL's financial statements and laugh out loud. It's a disposable product that experiences revenue spikes when a new product or campaign is launched, followed by significant and alarming DECREASES in revenue.

That's all the evidence an experienced biotech or biopharma needs to see.

The NOPAIN Act doesn't guarantee sales for BIEL. It doesn't even guarantee market exposure of RecoveryRx. Maybe revenues will increase in 2025 or 2026, maybe not, but nobody is going to buy this company or merge with this company until they see evidence that there's a market for this device.

The worse a pinkie biotech gets, the louder the shouting gets about a BUYOUT.